David Richardson

David Richardson OSF, D.D. studied at the University of California San Diego, University of Sydney. He brings 21 years of experience in the Biopharmaceutical Industry. David was a member of a team conducting leukemia research and was published in Lancet. He has held positions at B. Braun Biotech, CARR Separations, Westfalia Separator, Celeros and PSAngelus